The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSO4.L Regulatory News (SO4)

  • There is currently no data for SO4

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B and Section 708A Notice

5 Apr 2016 07:00

RNS Number : 1001U
Salt Lake Potash Limited
05 April 2016
 

5 April 2016

 

AIM/ASX Code: SO4

 

 

SALT LAKE POTASH LIMITED

Appendix 3B and Section 708A Notice

 

 

 

The Directors of Salt Lake Potash Limited (AIM/ASX: SO4) today released the following announcement on the Australian Securities Exchange ("ASX") as required under the listing rules of the ASX.

 

 

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

 SALT LAKE POTASH LIMITED

 

ABN

 98 117 085 748

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

Ordinary Shares

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

26,175,000

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Fully paid ordinary shares

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

 

 

 

5

Issue price or consideration

 

$0.32

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

 

 

To provide funding for the Company's planned exploration and development activities for the Lake Wells Project and for general working capital.

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

27 November 2015

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

15,605,389

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

10,569,611

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

Nil

 

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

Nil

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

Yes

 

Issue date: 31 March 2016

Issue price: $0.32

15 day VWAP: $0.3878 (Source: IRESS)

 

Issue date: 4 April 2016

Issue price: $0.32

15 day VWAP: $0.3675 (Source: IRESS)

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

Not Applicable

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

7.1 - Nil

7.1A - 648

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

31 March 2016: 16,250,000

4 April 2016: 9,925,000

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

132,227,596

Ordinary Shares

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

57,370

 

 

 

57,370

 

 

 

57,370

 

 

 

33,333

 

 

 

5,000,000

 

 

7,500,000

 

 

10,000,000

$3.60 Unlisted Options expiring 30 November 2016

 

$4.80 Unlisted Options expiring 30 November 2016

 

$6.00 Unlisted Options expiring 30 November 2016

 

$2.73 Unlisted Options expiring 30 November 2016

 

Class A Performance Shares

 

Class B Performance Shares

 

Class C Performance Shares

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Not Applicable

 

 

Part 2 ‑ Pro rata issue

 

11

Is security holder approval required?

 

Not Applicable

12

Is the issue renounceable or non-renounceable?

Not Applicable

13

Ratio in which the +securities will be offered

Not Applicable

14

+Class of +securities to which the offer relates

Not Applicable

15

+Record date to determine entitlements

Not Applicable

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

Not Applicable

17

Policy for deciding entitlements in relation to fractions

 

Not Applicable

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

Not Applicable

19

Closing date for receipt of acceptances or renunciations

Not Applicable

20

Names of any underwriters

 

 

Not Applicable

21

Amount of any underwriting fee or commission

Not Applicable

22

Names of any brokers to the issue

 

 

Not Applicable

23

Fee or commission payable to the broker to the issue

Not Applicable

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

Not Applicable

25

If the issue is contingent on security holders' approval, the date of the meeting

Not Applicable

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

Not Applicable

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

Not Applicable

28

Date rights trading will begin (if applicable)

Not Applicable

29

Date rights trading will end (if applicable)

 

 

Not Applicable

30

How do security holders sell their entitlements in full through a broker?

Not Applicable

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

Not Applicable

 

 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

Not Applicable

33

+Issue date

 

 

Not Applicable

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of +securities

(tick one)

 

(a)

+Securities described in Part 1

 

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

 Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

37

A copy of any trust deed for the additional +securities

 

 

 

Entities that have ticked box 34(b)

 

38

Number of +securities for which +quotation is sought

 

Not Applicable

 

 

39

+Class of +securities for which quotation is sought

 

Not Applicable

 

 

40

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Not Applicable

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 

Not Applicable

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

 

 

 

 

 

 

 

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Sign here: ............................................................ Date: 5 April 2016

(Director/Company secretary)

 

 

Print name: Sam Cordin

 

== == == == ==

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

90,702,596

Add the following:

• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

• Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid +ordinary securities that became fully paid in that 12 month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

15,000,000 (12 June 2015)

Subtract the number of fully paid +ordinary securities cancelled during that 12 month period

Nil

"A"

105,702,596

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

15,855,389

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

 

250,000 (8 July 2015)

15,605,389 (31 March 2016)

 

"C"

15,855,389

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

15,855,389

Subtract "C"

Note: number must be same as shown in Step 3

15,855,389

Total ["A" x 0.15] - "C"

Nil

[Note: this is the remaining placement capacity under rule 7.1]

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

105,702,596

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

10,570,259

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

644,611 (31 March 2016)

9,925,000 (4 April 2016)

"E"

10,569,611

 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

10,570,259

Subtract "E"

Note: number must be same as shown in Step 3

10,569,611

Total ["A" x 0.10] - "E"

648

Note: this is the remaining placement capacity under rule 7.1A

 

NOTICE UNDER SECTION 708A

 

Salt Lake Potash Limited (the Company) has issued 9,925,000 fully paid ordinary shares. The issued securities are part of a class of securities quoted on the Australian Securities Exchange ("ASX").

 

The Company hereby notifies ASX under paragraph 708A(5)(e) of the Corporations Act 2001 (Cwth) (the "Act") that:

1. the Company issued the securities without disclosure to investors under Part 6D.2 of the Act;

2. as at the date of this notice, the Company has complied with the provisions of Chapter 2M of the Act as they apply to the Company, and section 674 of the Act; and

3. as at the date of this notice, there is no information that is "excluded information" within the meaning of sections 708A(7) and 708A(8) of the Act.

 

+ See chapter 19 for defined terms.

 

For further information please visit www.saltlakepotash.com.au or contact:

Sam Cordin

Salt Lake Potash Limited

Tel: +61 8 9322 6322

Colin Aaronson/Richard Tonthat/Daniel Bush

Grant Thornton UK LLP (Nominated Adviser)

Tel: +44 (0) 207 383 5100

Nick Tulloch/Beth McKiernan

Cenkos Securities plc (Broker)

Tel: +44 (0) 131 220 6939

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXZLFBQZFXBBE
Date   Source Headline
19th Nov 20216:00 pmRNSSalt Lake Potash
21st Oct 202111:00 amRNSResignation of Nominated Adviser
20th Oct 20217:24 amRNSAppointment of Receivers and Managers
20th Oct 20217:00 amRNSAppointment of Voluntary Administrators
19th Oct 20217:41 amRNSStatement re. Suspension
15th Oct 20212:05 pmRNSSecond Price Monitoring Extn
15th Oct 20212:00 pmRNSPrice Monitoring Extension
15th Oct 202111:05 amRNSSecond Price Monitoring Extn
15th Oct 202111:00 amRNSPrice Monitoring Extension
15th Oct 20219:05 amRNSSecond Price Monitoring Extn
15th Oct 20219:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSASX Suspension Update
1st Oct 20217:00 amRNSFinal Results
29th Sep 20217:00 amRNSDate of AGM
23rd Sep 20219:49 amRNSHolding(s) in Company
23rd Sep 20218:42 amRNSASX Suspension Update
13th Sep 20217:00 amRNSAppointment of CEO
9th Sep 20217:00 amRNSASX Suspension Update
27th Aug 20217:00 amRNSResignation of CEO
27th Aug 20217:00 amRNSASX Suspension Update
16th Aug 20217:00 amRNSUpdate on ASX Suspension
12th Aug 20217:00 amRNSAppointment of Company Secretary
11th Aug 20217:00 amRNSIssue of Placement Shares to Directors
30th Jul 20211:03 pmRNSJune 2021 Quarterly Report
30th Jul 202111:06 amRNSSecond Price Monitoring Extn
30th Jul 202111:00 amRNSPrice Monitoring Extension
29th Jul 20219:05 amRNSSecond Price Monitoring Extn
29th Jul 20219:00 amRNSPrice Monitoring Extension
29th Jul 20217:30 amRNSRestoration - Salt Lake Potash Limited
29th Jul 20217:00 amRNSLake Way Project, Financing and Suspension Update
27th Jul 20218:32 amRNSStatement re. Suspension
27th Jul 20218:30 amRNSSuspension - Salt Lake Potash Ltd
15th Jul 20217:00 amRNSAppointment of Chief Financial Officer
13th Jul 202110:30 amRNSReplacement: Results of General Meeting
13th Jul 20217:00 amRNSResults of General Meeting
2nd Jul 20217:00 amRNSAppointment of Non-executive Director
1st Jul 20217:00 amRNSLake Way Project & Commissioning Update
10th Jun 20217:00 amRNSFunds from placement and final debt drawdown
7th Jun 20217:00 amRNSHolding(s) in Company
28th May 202111:30 amRNSInstitutional Placement Admission Dates
24th May 20217:00 amRNSInstitutional Placement. Equity Raise Presentation
21st May 20214:41 pmRNSSecond Price Monitoring Extn
21st May 20214:35 pmRNSPrice Monitoring Extension
21st May 20212:05 pmRNSSecond Price Monitoring Extn
21st May 20212:00 pmRNSPrice Monitoring Extension
21st May 20217:00 amRNSASX Trading Halt
4th May 20217:00 amRNSDirectorate Change
30th Apr 20217:00 amRNSMarch 2021 Quarterly Report
29th Apr 20217:00 amRNSGrant of Environmental Permit
28th Apr 202112:30 pmRNSCompany Secretary Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.